image
Altamira Therapeutics Ltd. CYTO
Healthcare - Biotechnology - NASDAQ - BM
Watchlist
$ 0.4554
5.91 %
$ 1.72 M
Market Cap
0.25
P/E
BALANCE SHEET
7.69 M ASSETS
22.08%
Growth Rates
1Year 22.08%
3Years -28.21%
5Years -4.87%
7Years -19.67%
10Years -11.55%
1.24 M LIABILITIES
-91.55%
Growth Rates
1Year -91.55%
3Years -32.57%
5Years -27.64%
7Years -33.51%
10Years -23.16%
6.46 M EQUITY
177.68%
Growth Rates
1Year 177.68%
3Years -27.24%
5Years 12.09%
7Years -10.59%
10Years -3.30%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Altamira Therapeutics Ltd.
image
Current Assets 1.22 M
Cash & Short-Term Investments 617 K
Receivables 74.8 K
Other Current Assets 531 K
Non-Current Assets 6.47 M
Long-Term Investments 2.5 M
PP&E 80.1 K
Other Non-Current Assets 3.89 M
Current Liabilities 889 K
Accounts Payable 413 K
Short-Term Debt 99.7 K
Other Current Liabilities 376 K
Non-Current Liabilities 347 K
Long-Term Debt 0
Other Non-Current Liabilities 347 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 0.6 15.4 K 1.0 11.3 1.4 5.4 15.0 32.4 50.2 56.9 23.9 64 K 0.8
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 72.8 K
Receivables 74.8 K 6.52 K 21.7 K 0 0 0 0 0.2 0.7 91.3 K 73.6 K 0 0.1
Inventory 0 11.6 K 0.8 (358.2) (988.5) 80 K 79.8 K 0 (0.5) 0.2 0.6 0.2 0
Other Current Assets 0.5 1.0 2.2 0.3 0.7 0.4 0.7 1.0 0.6 0.7 0.6 0.2 77.9 K
Total Current Assets 1.2 1.8 3.8 11.6 2.4 6.1 15.9 33.7 51.1 57.7 24.6 0.4 1.0
PP&E 80.1 K 0.4 0.6 46.6 K 66.7 K 33.9 K 0.3 0.4 0.2 0.2 0.2 0.1 1.99 K
Intangible Assets 3.9 3.9 14.3 9.1 6.8 3.5 1.6 1.5 1.5 1.5 1.5 0.4 0.4
Goodwill 0 0 0 0 0 0 0 0 480 480 0 0 0
Long Term Investments 2.5 0.2 0.2 20 K 0 0 0 0 0 2.6 0 0 0
Other Long Term Assets 0 (4.5) (15.1) (9.2) 20 K 0.2 76.7 K 0.1 38 K (2.6) 0 (0.5) 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 7.7 6.3 18.8 20.8 9.2 9.9 17.8 35.7 52.8 59.5 26.3 0.9 1.4
LIABILITIES
Accounts Payable 0.4 4.8 3.5 0.7 0.9 1.8 1.0 1.7 1.0 3.1 0.9 0.4 0.1
Short Term Debt 99.7 K 6.0 0.1 0.5 0 1.4 4.5 2.2 0 0 13.7 0 0
Other Current Liabilities 0.4 2.1 1.2 1.8 1.4 1.3 4.9 5.0 5.2 1.3 1.9 0.5 0.6
Total Current Liabilities 0.9 12.9 4.9 3.0 2.3 4.6 10.4 9.0 6.2 4.4 16.6 0.9 0.7
Long Term Debt 0 0.3 0.5 0 0 0 5.6 10.2 0 0 0 0 0
Deferred Tax Income 0 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.3 0.4 0.3 0 0
Other Liabilities 0.3 1.4 0.8 0.9 0.8 1.3 4.0 2.4 1.6 1.4 0.3 0.2 0.2
Total Liabilities 1.2 14.6 6.1 4.0 3.2 6.2 20.0 21.5 8.1 6.2 17.2 1.1 0.9
EQUITY
Common Stock 2.65 K 0.2 0.1 0.1 1.7 0.7 19.3 13.7 13.7 11.6 6.5 4.6 4.6
Retained Earnings (18.0) (201.4) (176.0) (160.6) (152.8) (146.3) (136.1) (112.3) (81.6) (52.1) (33.1) (18.2) (13.6)
Other Accumulative Comprehensive Income/Loss 0.2 0.3 62.1 K 61.3 K 27.6 K 44 K 33 K 83.5 K 64 K 51 K 54 K 22.3 K 0
Total Equity 6.5 (8.3) 12.7 16.8 6.0 3.6 (2.2) 14.1 44.7 53.3 9.0 (0.2) 0.5
Total Liabilities and Equity 7.7 6.3 18.8 20.8 9.2 9.9 17.8 35.7 52.8 59.5 26.3 0.9 1.4
SHARES OUTSTANDING
Common Shares Outstanding 0.5 45.5 K 33.1 K 15 K 14.5 K 3.98 K 1.09 K 858 807 692 451 451